Prof. Dr. Alexander Pfeifer
Institute of Pharmacology and Toxicology
alexander.pfeifer@uni-bonn.de View member: Prof. Dr. Alexander Pfeifer
Nature communications
A long-held tenet in inositol-lipid signaling is that cleavage of membrane phosphoinositides by phospholipase Cβ (PLCβ) isozymes to increase cytosolic Ca in living cells is exclusive to Gq- and Gi-sensitive G protein-coupled receptors (GPCRs). Here we extend this central tenet and show that Gs-GPCRs also partake in inositol-lipid signaling and thereby increase cytosolic Ca. By combining CRISPR/Cas9 genome editing to delete Gα, the adenylyl cyclase isoforms 3 and 6, or the PLCβ1-4 isozymes, with pharmacological and genetic inhibition of Gq and G11, we pin down Gs-derived Gβγ as driver of a PLCβ2/3-mediated cytosolic Ca release module. This module does not require but crosstalks with Gα-dependent cAMP, demands Gα to release PLCβ3 autoinhibition, but becomes Gq-independent with mutational disruption of the PLCβ3 autoinhibited state. Our findings uncover the key steps of a previously unappreciated mechanism utilized by mammalian cells to finetune their calcium signaling regulation through Gs-GPCRs.
© 2024. The Author(s).
PMID: 39227390
Institute of Pharmacology and Toxicology
alexander.pfeifer@uni-bonn.de View member: Prof. Dr. Alexander PfeiferInstitute of Innate Immunity
dwachten@uni-bonn.de View member: Prof. Dr. Dagmar Wachten